Background: The sc-PDB database is an annotated archive of druggable binding sites extracted from the Protein Data Bank. It contains all-atoms coordinates for 8 166 protein-ligand complexes, chosen for their geometrical and physico-chemical properties. The sc-PDB provides a functional annotation for proteins, a chemical description for ligands and the detailed intermolecular interactions for complexes. The sc-PDB now includes a hierarchical classifica-tion of all the binding sites within a functional class. Method: The sc-PDB entries were first clustered according to the protein name indifferently of species. For each cluster, we identified dissimilar sites (e.g., catalytic and allosteric sites of an enzyme). Scope and applications: The cla...
BindingDB (http://www.bindingdb.org) is a publicly accessible database currently containing approxim...
SummaryComprehensive knowledge of protein-ligand interactions should provide a useful basis for anno...
A key concept in drug design is how natural variants, especially the ones occurring in the binding s...
The sc-PDB is a collection of 6 415 three-dimensional structures of binding sites found in the Prote...
In computational structure-based drug design, the scoring functions are the cornerstones to the succ...
Motivation: Recognition of functional sites in proteins is a direct computational approach providing...
SummaryComprehensive knowledge of protein-ligand interactions should provide a useful basis for anno...
<div><p>The residue composition of a ligand binding site determines the interactions available for d...
We have developed a new computational algorithm for de novo identification of protein-ligand bindin...
After the onset of the genomic era, the detection of ligand binding sites in proteins has emerged ov...
After the onset of the genomic era, the detection of ligand binding sites in proteins has emerged ov...
International audienceThe number of available protein structures in the Protein Data Bank (PDB) has ...
The design of a chemical entity that potently and selectively binds to a biological target of therap...
International audienceThe number of available protein structures in the Protein Data Bank (PDB) has ...
The design of a chemical entity that potently and selectively binds to a biological target of therap...
BindingDB (http://www.bindingdb.org) is a publicly accessible database currently containing approxim...
SummaryComprehensive knowledge of protein-ligand interactions should provide a useful basis for anno...
A key concept in drug design is how natural variants, especially the ones occurring in the binding s...
The sc-PDB is a collection of 6 415 three-dimensional structures of binding sites found in the Prote...
In computational structure-based drug design, the scoring functions are the cornerstones to the succ...
Motivation: Recognition of functional sites in proteins is a direct computational approach providing...
SummaryComprehensive knowledge of protein-ligand interactions should provide a useful basis for anno...
<div><p>The residue composition of a ligand binding site determines the interactions available for d...
We have developed a new computational algorithm for de novo identification of protein-ligand bindin...
After the onset of the genomic era, the detection of ligand binding sites in proteins has emerged ov...
After the onset of the genomic era, the detection of ligand binding sites in proteins has emerged ov...
International audienceThe number of available protein structures in the Protein Data Bank (PDB) has ...
The design of a chemical entity that potently and selectively binds to a biological target of therap...
International audienceThe number of available protein structures in the Protein Data Bank (PDB) has ...
The design of a chemical entity that potently and selectively binds to a biological target of therap...
BindingDB (http://www.bindingdb.org) is a publicly accessible database currently containing approxim...
SummaryComprehensive knowledge of protein-ligand interactions should provide a useful basis for anno...
A key concept in drug design is how natural variants, especially the ones occurring in the binding s...